Nvigen Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Nvigen

Access the complete profile.

Nvigen Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325413 In-Vitro Diagnostic Substance Manufacturing
Additional NAICS Codes	5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology
Address	1875 South Winchester Blvd. #203 Campbell, CA 95008

Note: Revenues for privately held companies are statistical evaluations.


Nvigen's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Nvigen's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Nvigen is classified as operating in the In-Vitro Diagnostic Substance Manufacturing industry, NAICS Code 325413.

Nvigen Annual Revenue and Growth Rate

Nvigen	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Nvigen's revenues are gauged from an analysis of company filings.

Nvigen's Income Statement (based on Industry Averages)

Nvigen P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Nvigen is developing and marketing. Nvigen doesn't have any recent trademark applications, indicating Nvigen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NERNST-SEQ Custom design and development of chemical reagents and biochemical assays	06/02/2022
NVIGEN Biotechnology research; Development of new technology for others in the field of genomics, biotechnology, medical and clinical diagnostics, therapeutics; Research and development in the pharmaceutical and biotechnology fields	07/10/2014

See all trademarks and details in the Full Report.

Market Share of Nvigen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Nvigen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CUE HEALTH	San Diego, CA	100
ACCESS BIO	Somerset, NJ	24
AALTO SCIENTIFIC	Eatonton, GA	17
LUMINOSTICS	Fremont, CA	7
SDIX	Newark, DE	4
SEDIA BIOSCIENCES	Beaverton, OR	3
ZEPTO LIFE TECHNOLOGY	Saint Paul, MN	3
ARLINGTON SCIENTIFIC	Springville, UT	2
BIOPOOL US	Jamestown, NY	2

Nearby Competitors

These companies are similar in business line and location to Nvigen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ALPHA TEKNOVA	Hollister, CA	100
FOSUN PHARMA USA	Santa Clara, CA	28
VIVUS	Campbell, CA	17
NOODLE & BOO	Los Gatos, CA	3
HANDA PHARMACEUTICALS	Saratoga, CA	3
RASILIENT SYSTEMS	Santa Clara, CA	2

Future Competition: Nvigen's Fastest Growing Competitors

These companies are in the same general field as Nvigen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)